Gain-of-function mutations in Leucine-rich repeat kinase 2 (LRRK2) are associated with autosomal dominant Parkinson’s disease (PD) and are frequently found in sporadic PD patients (1, –3). The gene discussed is LRRK2; the disease is Parkinson disease.